Storbritannien -
engelska -
MHRA (Medicines & Healthcare Products Regulatory Agency)
memantine 10mg tablets
mylan - memantine hydrochloride - tablet - 10mg
Storbritannien -
engelska -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alzhok 10mg soluble tablets
glenmark pharmaceuticals europe ltd - memantine hydrochloride - soluble tablet - 10mg
Storbritannien -
engelska -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alzhok 20mg soluble tablets
glenmark pharmaceuticals europe ltd - memantine hydrochloride - soluble tablet - 20mg
Storbritannien -
engelska -
MHRA (Medicines & Healthcare Products Regulatory Agency)
opdivo 240mg24ml concentrate for solution for infusion vials
bristol-myers squibb pharmaceuticals ltd - nivolumab - solution for infusion - 10mg/1ml
Saudiarabien -
engelska -
SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء
opdivo 10 mg/ml solution for injection
bristol-myers squibb, united states - nivolumab - solution for injection - 10 mg/ml
Saudiarabien -
engelska -
SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء
opdivo 10 mg/ml solution for injection
bristol-myers squibb, united states - nivolumab - solution for injection - 10 mg/ml
Singapore -
engelska -
HSA (Health Sciences Authority)
opdualag concentrate for solution for infusion 240mg80mg
bristol-myers squibb (singapore) pte. ltd. - nivolumab; relatlimab - infusion, solution concentrate - nivolumab 240mg per vial; relatlimab 80mg per vial
Japan -
engelska -
すりの適正使用協議会 RAD-AR Council, Japan
opdivo intravenous infusion 100mg (オプジーボ点滴静注100mg)
ono pharmaceutical co., ltd. - nivolumab (genetical recombination) - injection
Japan -
engelska -
すりの適正使用協議会 RAD-AR Council, Japan
opdivo intravenous infusion 100mg (オプジーボ点滴静注100mg)
bristol-myers squibb - nivolumab (genetical recombination) - injection
Japan -
engelska -
すりの適正使用協議会 RAD-AR Council, Japan
opdivo intravenous infusion 120mg (オプジーボ点滴静注120mg)
bristol-myers squibb - nivolumab (genetical recombination) - injection